[PLX] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 56.25%
YoY- 26.81%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 679 5,097 7,383 3,968 3,728 6,000 1,141 -8.27%
PBT -8,526 -5,972 -7,345 -4,321 0 -5,052 -7,955 1.16%
Tax 314 28 38 0 -161 0 0 -
NP -8,598 -5,972 -7,345 -4,321 -5,904 -5,052 -7,955 1.30%
Tax Rate - - - - - - - -
Total Cost 9,277 11,069 14,728 8,289 9,632 11,052 9,096 0.32%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -1,266.27 -117.17 -99.49 -108.90 -158.37 -84.20 -697.20 10.44%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -0.09 -0.06 -0.08 -0.05 -0.07 -0.06 -0.10 -1.73%
EPS Diluted -0.09 -0.06 -0.08 -0.05 -0.07 -0.06 -0.10 -1.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.